{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:04:28Z","timestamp":1784642668573,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T00:00:00Z","timestamp":1535328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11657-018-0507-8","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T12:58:04Z","timestamp":1535374684000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Progressive bone impairment with age and pubertal development in neurofibromatosis type I"],"prefix":"10.1007","volume":"13","author":[{"given":"Giulia","family":"Rodari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Scuvera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. M.","family":"Ulivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Profka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Menni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Saletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bergamaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Eller-Vainicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Arosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Giavoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,27]]},"reference":[{"key":"507_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152A","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 152A:327\u2013332. \n                    https:\/\/doi.org\/10.1002\/ajmg.a.33139","journal-title":"Am J Med Genet A"},{"key":"507_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrc3911","volume":"15","author":"N Ratner","year":"2015","unstructured":"Ratner N, Miller SJ (2015) A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer 15:290\u2013301. \n                    https:\/\/doi.org\/10.1038\/nrc3911","journal-title":"Nat Rev Cancer"},{"key":"507_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jama.1997.03550010065042","volume":"278","author":"DH Gutmann","year":"1997","unstructured":"Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51\u201357. \n                    https:\/\/doi.org\/10.1001\/jama.1997.03550010065042","journal-title":"JAMA"},{"key":"507_CR4","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0733-8619(01)00019-6","volume":"20","author":"TM Lynch","year":"2002","unstructured":"Lynch TM, Gutmann DH (2002) Neurofibromatosis 1. Neurol Clin 20:841\u2013865. \n                    https:\/\/doi.org\/10.1016\/S0733-8619(01)00019-6","journal-title":"Neurol Clin"},{"key":"507_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.pediatrneurol.2004.11.002","volume":"32","author":"BA Ward","year":"2005","unstructured":"Ward BA, Gutmann DH (2005) Neurofibromatosis 1: from lab bench to clinic. Pediatr Neurol 32:221\u2013228. \n                    https:\/\/doi.org\/10.1016\/j.pediatrneurol.2004.11.002","journal-title":"Pediatr Neurol"},{"key":"507_CR6","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/ajmg.a.31758","volume":"143","author":"DA Stevenson","year":"2007","unstructured":"Stevenson DA, Viskochil DH, Carey JC (2007) Neurofibromatosis type 1 is a genetic skeletal disorder. Am J Med Genet A 143:2082\u20132083. \n                    https:\/\/doi.org\/10.1002\/ajmg.a.31758","journal-title":"Am J Med Genet A"},{"key":"507_CR7","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/j.1651-2227.2007.00401.x","volume":"96","author":"K Yilmaz","year":"2007","unstructured":"Yilmaz K, Ozmen M, Bora Goksan S, Eskiyurt N (2007) Bone mineral density in children with neurofibromatosis 1. Acta Paediatr 96:1220\u20131222. \n                    https:\/\/doi.org\/10.1111\/j.1651-2227.2007.00401.x","journal-title":"Acta Paediatr"},{"key":"507_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jpeds.2006.10.048.","volume":"150","author":"DA Stevenson","year":"2008","unstructured":"Stevenson DA, Moyer-Mileur LJ, Murray M, Slater H, Sheng X, Carey JC, Dube B, Viskochil DH (2008) Bone mineral density in children and adolescents with neurofibromatosis type 1. J Pediatr 150:83\u201388. \n                    https:\/\/doi.org\/10.1016\/j.jpeds.2006.10.048.","journal-title":"J Pediatr"},{"key":"507_CR9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/01.bpb.0000271310.87997.ae","volume":"27","author":"S Dulai","year":"2007","unstructured":"Dulai S, Briody J, Schindeler A, North KN, Cowell CT, Little DG (2007) Decreased bone mineral density in neurofibromatosis type 1: results from a pediatric cohort. J Pediatr Orthop 27:472\u2013475. \n                    https:\/\/doi.org\/10.1097\/01.bpb.0000271310.87997.ae","journal-title":"J Pediatr Orthop"},{"key":"507_CR10","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.braindev.2008.02.002","volume":"30","author":"O Duman","year":"2008","unstructured":"Duman O, Ozdem S, Turkkaharaman D, Olgac ND, Gungor F, Haspolat S (2008) Bone metabolism markers and bone mineral density in children with neurofibromatosis type-1. Brain and Development 30:584\u2013588. \n                    https:\/\/doi.org\/10.1016\/j.braindev.2008.02.002","journal-title":"Brain and Development"},{"key":"507_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ymgme.2007.12.004","volume":"94","author":"N Brunetti-Pierri","year":"2008","unstructured":"Brunetti-Pierri N, Doty SB, Hicks J, Phan K, Mendoza-Londono R, Blazo M, Tran A, Carter S, Lewis RA, Plon SE, Phillips WA, O\u2019Brian Smith E, Ellis KJ, Lee B (2008) Generalized metabolic bone disease in neurofibromatosis type I. Mol Genet Metab 94:105\u2013111. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2007.12.004","journal-title":"Mol Genet Metab"},{"key":"507_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jocd.2009.10.002","volume":"13","author":"C Caffarelli","year":"2010","unstructured":"Caffarelli C, Gonnelli S, Tanzilli L, Vivarelli R, Tamburello S, Balestri P, Nuti R (2010) Quantitative ultrasound and dual-energy x-ray absorptiometry in children and adolescents with neurofibromatosis of type 1. J Clin Densitom 13:77\u201383. \n                    https:\/\/doi.org\/10.1016\/j.jocd.2009.10.002","journal-title":"J Clin Densitom"},{"key":"507_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1530\/ERC-12-0293","volume":"19","author":"MB Lodish","year":"2012","unstructured":"Lodish MB, Dagalakis U, Sinali N, Bornstein E, Kim A, Lokie KB, Baldwin AM, Reynolds JC, Dombi E, Stratakis CA, Widemann BC (2012) Bone mineral density in children and young adults with neurofibromatosis type 1. Endocr Relat Cancer 19:817\u2013825. \n                    https:\/\/doi.org\/10.1530\/ERC-12-0293","journal-title":"Endocr Relat Cancer"},{"key":"507_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S1043-2760(00)00336-2","volume":"12","author":"LK Bachrach","year":"2001","unstructured":"Bachrach LK (2001) Acquisition of optimal bone mass in childhood and adolescence. Trends Endocrinol Metab 12:22\u201328. \n                    https:\/\/doi.org\/10.1016\/S1043-2760(00)00336-2","journal-title":"Trends Endocrinol Metab"},{"key":"507_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bone.2009.10.005","volume":"46","author":"R Rizzoli","year":"2010","unstructured":"Rizzoli R, Bianchi ML, Garab\u00e8dian M, McKay HA, Moreno LA (2010) Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly. Bone 46:294\u2013305. \n                    https:\/\/doi.org\/10.1016\/j.bone.2009.10.005","journal-title":"Bone"},{"key":"507_CR16","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/ajmg.a.35541","volume":"161","author":"JK George-Abraham","year":"2013","unstructured":"George-Abraham JK, Martin LJ, Kalkwarf HJ, Rieley MB, Stevenson DA, Viskochil DH, Hopkin RJ, Stevens AM, Hanson H, Schorry EK (2013) Fractures in children with neurofibromatosis type 1 from two NF clinics. Am J Med Genet A 161:921\u2013926. \n                    https:\/\/doi.org\/10.1002\/ajmg.a.35541","journal-title":"Am J Med Genet A"},{"key":"507_CR17","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1002\/jbmr.1685","volume":"27","author":"E Heerv\u00e4","year":"2012","unstructured":"Heerv\u00e4 E, Koffert A, Jokinen E, Kuorilehto T, Peltonen S, Aro HT, Peltonen J (2012) A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age. J Bone Miner Res 27:2333\u20132337. \n                    https:\/\/doi.org\/10.1002\/jbmr.1685","journal-title":"J Bone Miner Res"},{"key":"507_CR18","unstructured":"2013 ISCD Official Positions - Paediatric - International Society for Clinical Densitometry (ISCD). \n                    http:\/\/www.iscd.org\/official-positions\/2013-iscd-official-positions-pediatric\/\n                    \n                  . Accessed 13 Sept 2016"},{"key":"507_CR19","unstructured":"National Institutes of Health Consensus Development Conference (1988) Neurofibromatosis. NIH Consens Statement 1987 Jul 13\u201315; 6:1\u201319"},{"key":"507_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/adc.51.3.170","volume":"51","author":"JM Tanner","year":"1976","unstructured":"Tanner JM, Whitehouse RH (1976) Clinical longitudinal standards for height, weight, height velocity, weight velocity, and the stages of puberty. Arch Dis Child 51:170\u2013179. \n                    https:\/\/doi.org\/10.1136\/adc.51.3.170","journal-title":"Arch Dis Child"},{"key":"507_CR21","volume-title":"Radiographic atlas of skeletal development of the hand and wrist","author":"WW Greulich","year":"1959","unstructured":"Greulich WW, Pyle SL (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd edn. Stanford University Press, Stanford","edition":"2"},{"key":"507_CR22","first-page":"260","volume-title":"Dietary reference intakes for calcium and vitamin D","author":"Institute of Medicine (IOM)","year":"2011","unstructured":"Institute of Medicine (IOM) (2011) Dietary reference intakes for calcium and vitamin D. The National Academies Press, Washington, pp 260\u2013262"},{"key":"507_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/000456329803500203","volume":"35","author":"RB Payne","year":"1198","unstructured":"Payne RB (1198) Renal tubular reabsorption of phosphate, (TmP\/GFR): indications and interpretation. Ann Clin Biochem 35:201\u2013206","journal-title":"Ann Clin Biochem"},{"key":"507_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/adc.2006.097642","volume":"92","author":"KA Ward","year":"2007","unstructured":"Ward KA, Ashby RL, Roberts SA, Adams JE, Zulf Mughal M (2007) UK reference data for the Hologic QDR Discovery dual-energy x ray absorptiometry scanner in healthy children and young adults aged 6\u201317 years. Arch Dis Child 92:53\u201359. \n                    https:\/\/doi.org\/10.1136\/adc.2006.097642","journal-title":"Arch Dis Child"},{"key":"507_CR25","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.bone.2007.11.018","volume":"42","author":"L Pothuaud","year":"2008","unstructured":"Pothuaud L, Carceller P, Hans D (2008) Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture. Bone 42:775\u2013787","journal-title":"Bone"},{"issue":"2","key":"507_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jocd.2008.11.006","volume":"12","author":"L Pohuaud","year":"2009","unstructured":"Pohuaud L, Barthe N, Krieg MA, Mehsen N, Carceller P, Hans D (2009) Evaluation of the potential use of trabecular bone score to complement bone mineral density in the diagnosis of osteoporosis: a preliminary spine BMD-matched, case-control study. J Clin Densitom 12(2):170\u2013176. \n                    https:\/\/doi.org\/10.1016\/j.jocd.2008.11.006","journal-title":"J Clin Densitom"},{"key":"507_CR27","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00198-012-2008-8","volume":"24","author":"LM Rio Del","year":"2013","unstructured":"Del Rio LM, Winzenrieth R, Cormier C (2013) Di Gregorio, S. Is bone microarchitecture status of the lumbar spine assessed by TBS related to femoral neck fracture? A Spanish case-control study. Osteoporos Int 24:991\u2013998","journal-title":"Osteoporos Int"},{"issue":"3","key":"507_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jocd.2015.06.008","volume":"18","author":"BC Silva","year":"2015","unstructured":"Silva BC, Broy SB, Boutroy S, Schousboe JT, Shepherd JA, Leslie WD (2015) Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD official positions part 2: trabecular bone score. J Clin Densitom 18(3):309\u2013330. \n                    https:\/\/doi.org\/10.1016\/j.jocd.2015.06.008","journal-title":"J Clin Densitom"},{"issue":"6","key":"507_CR29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/MED.0000000000000365","volume":"24","author":"P Martineau","year":"2017","unstructured":"Martineau P, Silva BC, Leslie WD (2017) Utility of trabecular bone score in the evaluation of osteoporosis. Curr Opin Endocrinol Diabetes Obes 24(6):402\u2013410. \n                    https:\/\/doi.org\/10.1097\/MED.0000000000000365","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"507_CR30","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1002\/jbmr.499","volume":"26","author":"D Hans","year":"2011","unstructured":"Hans D, Goertzen AL, Krieg MA, Leslie WD (2011) Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res Off J Am Soc Bone Miner Res 26:2762\u20132769","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"507_CR31","unstructured":"Gockenbach MS (2008) Understanding and Implementing the finite element method. Society for Industrial and Applied Mathematics"},{"key":"507_CR32","volume-title":"The finite element method for solid and structural mechanics","author":"O Zienkiewicz","year":"2005","unstructured":"Zienkiewicz O (2005) The finite element method for solid and structural mechanics. Butterworth-Heinemann, Oxford"},{"key":"507_CR33","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1002\/jbmr.2291","volume":"29","author":"L Yang","year":"2014","unstructured":"Yang L, Palermo L, Black DM, Eastell R (2014) Prediction of incident hip fracture with the estimated femoral strength by finite element analysis of DXA scans in the study of osteoporotic fractures. J Bone Miner Res 29:2594\u20132600. \n                    https:\/\/doi.org\/10.1002\/jbmr.2291","journal-title":"J Bone Miner Res"},{"key":"507_CR34","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1359\/jbmr.081201","volume":"24","author":"ES Orwoll","year":"2009","unstructured":"Orwoll ES, Marshall LM, Nielson CM, Cummings SR, Lapidus J, Cauley JA, Ensrud K, Lane N, Hoffmann PR, Kopperdahl DL, Keaveny TM, for the Osteoporotic Fractures in Men (MrOS) Study Group (2009) Finite element analysis of the proximal femur and hip fracture risk in older men. J Bone Miner Res 24:475\u2013483. \n                    https:\/\/doi.org\/10.1359\/jbmr.081201","journal-title":"J Bone Miner Res"},{"key":"507_CR35","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1093\/hmg\/ddl208.","volume":"15","author":"X Wu","year":"2006","unstructured":"Wu X, Estwick SA, Chen S, Yu M, Ming W, Nebesio TD, Li Y, Yuan J, Kapur R, Ingram D, Yoder MC, Yang FC (2006) Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem\/progenitor cells. Hum Mol Genet 15:2837\u20132845. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddl208.","journal-title":"Hum Mol Genet"},{"key":"507_CR36","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00198-015-3255-2","volume":"27","author":"K Shawwa","year":"2016","unstructured":"Shawwa K, Arabi A, Nabulsi M, Maalouf J, Salamoun M, Choucair M, Hans D, El-Hajj Fuleihan G (2016) Predictors of trabecular bone score in school children. Osteoporos Int 27:703\u2013710. \n                    https:\/\/doi.org\/10.1007\/s00198-015-3255-2","journal-title":"Osteoporos Int"},{"key":"507_CR37","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.bone.2010.06.001","volume":"47","author":"E Heerv\u00e4","year":"2010","unstructured":"Heerv\u00e4 E, Alanne MH, Peltonen S, Kuorilehto T, Hentunen T, V\u00e4\u00e4n\u00e4nen K, Peltonen J (2010) Osteoclasts in neurofibromatosis type 1 display enhanced resorption capacity, aberrant morphology, and resistance to serum deprivation. Bone 47:583\u2013590. \n                    https:\/\/doi.org\/10.1016\/j.bone.2010.06.001","journal-title":"Bone"},{"key":"507_CR38","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1203\/PDR.0b013e3181a1c607","volume":"65","author":"H Li","year":"2009","unstructured":"Li H, Liu Y, Zhang Q, Jing Y, Chen S, Song Z, Yan J, Li Y, Wu X, Zhang X, Zhang Y, Case J, Yu M, Ingram DA, Yang FC (2009) Ras dependent paracrine secretion of osteopontin by Nf1+\/- osteoblasts promote osteoclast activation in a neurofibromatosis type I murine model. Pediatr Res 65:613\u2013618. \n                    https:\/\/doi.org\/10.1203\/PDR.0b013e3181a1c607","journal-title":"Pediatr Res"},{"key":"507_CR39","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.bone.2005.01.022","volume":"36","author":"X Yu","year":"2005","unstructured":"Yu X, Chen S, Potter OL, Murthy SM, Li J, Pulcini JM, Ohashi N, Winata T, Everett ET, Ingram D, Clapp WD, Hock JM (2005) Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning. Bone 36:793\u2013802. \n                    https:\/\/doi.org\/10.1016\/j.bone.2005.01.022","journal-title":"Bone"},{"key":"507_CR40","doi-asserted-by":"publisher","first-page":"e24917","DOI":"10.1371\/journal.pone.0024917","volume":"6","author":"X Wu","year":"2011","unstructured":"Wu X, Chen S, He Y, Rhodes SD, Mohammad KS, Li X, Yang X, Jiang L, Nalepa G, Snider P, Robling AG, Clapp DW, Conway SJ, Guise TA, Yang FC (2011) The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1. PLoS One 6:e24917. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0024917","journal-title":"PLoS One"},{"key":"507_CR41","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1172\/JCI29092","volume":"116","author":"FC Yang","year":"2006","unstructured":"Yang FC, Chen S, Robling AG, Yu X, Nebesio TD, Yan J, Morgan T, Li X, Yuan J, Hock J, Ingram DA, Clapp DW (2006) Hyperactivation of p21 ras and PI3K cooperate to alter murine and human neurofibromatosis type 1- haploinsufficient osteoclast functions. J Clin Invest 116:2880\u20132891. \n                    https:\/\/doi.org\/10.1172\/JCI29092","journal-title":"J Clin Invest"},{"issue":"2","key":"507_CR42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1515\/jpem-2016-0092","volume":"30","author":"HG Poyrazo\u011flu","year":"2017","unstructured":"Poyrazo\u011flu HG, Ba\u015f VN, Arslan A, Bastug F, Canpolat M, Per H, G\u00fcm\u00fcs H, Kumandas S (2017) Bone mineral density and bone metabolic markers' status in children with neurofibromatosis type 1. J Pediatr Endocrinol Metab 30(2):175\u2013180. \n                    https:\/\/doi.org\/10.1515\/jpem-2016-0092","journal-title":"J Pediatr Endocrinol Metab"},{"key":"507_CR43","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s00198-005-1940-2","volume":"16","author":"M Lammert","year":"2005","unstructured":"Lammert M, Kappler M, Mautner VF, Lammert K, St\u00f6rkel S, Friedman JM, Atkins D (2005) Decreased bone mineral density in patients with neurofibromatosis 1. Osteoporos Int 16:1161\u20131166. \n                    https:\/\/doi.org\/10.1007\/s00198-005-1940-2","journal-title":"Osteoporos Int"},{"issue":"3\u20134","key":"507_CR44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1515\/jpem.2011.092","volume":"24","author":"DA Stevenson","year":"2011","unstructured":"Stevenson DA, Viskochil DH, Carey JC, Sheng X, Murray M, Moyer-Mileur L, Shelton J, Roberts WL, Bunker AM, Hanson H, Bauer S, D'Astous JL (2011) Pediatric 25-hydroxyvitamin D concentrations in neurofibromatosis type 1. J Pediatr Endocrinol Metab 24(3\u20134):169\u2013174. \n                    https:\/\/doi.org\/10.1515\/jpem.2011.092","journal-title":"J Pediatr Endocrinol Metab"},{"key":"507_CR45","first-page":"111","volume":"13","author":"CW Hockett","year":"2013","unstructured":"Hockett CW, Eelloo J, Huson SM, Roberts SA, Berry JL, Chaloner C, Rawer R, Mughal MZ (2013) Vitamin D status and muscle function in children with neurofibromatosis type 1 (NF1). J Musculoskelet Neuronal Interact 13:111\u2013119","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"507_CR46","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.clinbiochem.2014.02.020","volume":"47","author":"C Schnabel","year":"2014","unstructured":"Schnabel C, Dahm S, Streichert T, Thierfelder W, Kluwe L, Mautner VF (2014) Differences of 25-hydroxyvitamin D3 concentrations in children and adults with neurofibromatosis type 1. Clin Biochem 47:560\u2013563. \n                    https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.02.020","journal-title":"Clin Biochem"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11657-018-0507-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-018-0507-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-018-0507-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T23:14:55Z","timestamp":1566861295000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11657-018-0507-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,27]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["507"],"URL":"https:\/\/doi.org\/10.1007\/s11657-018-0507-8","relation":{},"ISSN":["1862-3522","1862-3514"],"issn-type":[{"value":"1862-3522","type":"print"},{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,27]]},"assertion":[{"value":"21 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"93"}}